#TREGS
Precision CAR-Tregs for autoimmunity offer a targeted approach to immune regulation within diseased tissues, minimizing systemic suppression.

🔗 Source: https://pubmed.ncbi.nlm.nih.gov/43056847/
November 21, 2026 at 6:56 AM
@biorxivpreprint.bsky.social CD8 Tregs may derive from the same TCR-directed developmental program that generates natural IELs
www.biorxiv.org/content/10.6...
November 14, 2026 at 5:16 PM
TNFR2 agonism expanded BATF+ tissue-primed Tregs and preserved FOXP3 stability markers. In mice, it reduced EAE and skin inflammation; human Tregs gained tissue-associated features. Promising, but preclinical. 🧬

doi.org/10.1093/jimm...

#Tregs #Immunotherapy
TNFR2 agonism increases tissue and effector Treg cells
Abstract. Autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus (SLE) are driven by chronic inflammation and tissue damage. Reg
doi.org
November 17, 2026 at 8:34 PM
Why are regulatory T-cells excluded from the brain?

How can Tregs be promoted, and used therapeutically for resolving and minimising brain injury?

Live from #VIB #Neuroimmunology26 Adrian Liston (Cambridge, UK) is sharing his work
November 20, 2026 at 4:49 PM
Target engagement is only half the story for anti-CCR8 antibodies. Fc-mediated Treg depletion matters too.

genO-hCCR8/hCCL1/hFcγR: tumor growth inhibition + higher CD8/Treg ratio.

📖 www.genoway.com/science/publ...

#CCR8 #Tregs
November 19, 2026 at 3:12 PM
Scientists in Dr. Nahal Mansouri's lab, including Nadine Fournier and Bruno Torchia at EPFL, discover that #basophils limit early lung metastasis by suppressing Tregs and enhancing anti-tumor CD8+ T cell responses in mice.

Read more: https://go.nature.com/4ArVv5O
🎧 Tune in: https://bit.ly/4jk0P5w
November 20, 2026 at 5:46 PM
Instead, we found that #TCRs from splenic Ly49+ CD8 Tregs deterministically direct natural IEL development.
November 14, 2026 at 1:18 PM
I want to propose another renaming of Thetis cells/Janus cells/RORgt+ DCs/ILC3s, or whatever you want to call the RORgt+ APCs that are responsible for generating RORgt+Tregs in the gut. I propose Treg inducer ILC3s (TRi-ILC3s), as their ontogeny resembles LTi-like ILC3s.
November 19, 2026 at 8:45 PM
Our findings suggest that CD8 Tregs may derive from the same #TCR-directed developmental program that generates natural IELs and shed light on the origins of these immunoregulatory cells.
November 14, 2026 at 1:18 PM
Data reveal the metabolic vulnerability of PD-1–deficient T-regs and underscore the importance of PD-1 in T-reg-mediated protection against acute kidney injury with implications for ischemia-reperfusion injury-related nephropathy. Read more here: https://ow.ly/KABR5107pKM.
November 17, 2026 at 7:00 PM
We are glad to report a #preprint from our lab in which we show #TCRs from #CD8Tregs direct the #development of natural #IELs. This work is done by a talentd student in our lab -Sam Murphy www.biorxiv.org/content/10.6...
T cell receptors from CD8 regulatory T cells direct the development of natural intraepithelial lymphocytes
CD8 regulatory T cells (CD8 Tregs) in mice have been identified by their expression of the surface receptor family Ly49 and the transcription factor Helios. To our surprise, many Ly49+ and Helios+ T c...
www.biorxiv.org
November 14, 2026 at 1:18 PM
Discover IL-2R agonists! Trispecific antibodies enhance Treg targeting, boosting activation by 3x. A new hope for autoimmune and transplant therapies! PMID:42431912, Nat Commun 2026, @NatureComms https://doi.org/10.1038/s41467-026-75024-6 #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪
Engineering trispecific IL-2 receptor agonistic antibodies through geometry optimization for enhanced Treg targeting | Nature Communications
Regulatory T cells (Tregs) are central to maintaining immune tolerance, and their selective activation via interleukin-2 (IL-2) signaling presents a promising therapeutic strategy for autoimmune diseases and transplant rejection. Here, we develop IL-2 receptor (IL-2R) agonists, employing trispecific antibodies that simultaneously engage all three IL-2R subunits. This design preferentially activates and expands Tregs over conventional T cells and natural killer cells that express the dimeric IL-2R (CD122 and CD132). Incorporation of a second CD25-targeting VHH domain confers further enhanced specificity and potency for CD25⁺ Tregs. Extensive engineering of antibody geometry was then critical to maximize Treg selectivity, highlighting the importance of spatial configuration in receptor engagement. This study reports the successful development of trispecific IL-2R-targeting antibodies and significantly expands the potential of antibody-based immunomodulation. By selectively activating the
doi.org
November 16, 2026 at 3:00 PM
UCL scientists, funded by Cancer Research UK, have found a buildup of immune cells (Tregs) in the lungs months or years before #LungCancer takes hold, dulling the body's own defences. Clearing them halved tumour rates in mice & a blood test is in development. A real lead for anyone with lungs. #LCSM
November 12, 2026 at 7:49 AM
Early infiltration of ischemia-conditioned Tregs attenuates BBB damage via suppressing neutrophil extracellular traps in ischemic stroke
Early infiltration of ischemia-conditioned Tregs attenuates BBB damage via suppressing neutrophil extracellular traps in ischemic stroke
“Right time, right place, right people equal success.” Li et al. demonstrate that physiological delayed Treg arrival after stroke permits neutrophil-mediated BBB injury, but timely Treg awakening (ICTreg) and deployment into the brain curbs neutrophils and safeguards the barrier.
dlvr.it
November 12, 2026 at 1:35 PM
'(...) conserved pathway of CD4 T cell plasticity, wherein intratumoral, cytotoxic KLRG1+ CD4 Tconv cells can be derived fm Tregs & maintain immunosuppressive function, despite loss of FoxP3, and that KLRG1-targeted depletion may outperform KLRG1 blockade as an immunotherapeutic strategy in cancer.'
Cytotoxic CD4+ exTregs expressing KLRG1 retain immunosuppressive function in cancer
The role of cytotoxic CD4+ T cells in cancer remains controversial, with both pro- and anti-tumor functionality described. Based on a prior observation that putatively cytotoxic KLRG1+ FoxP3- conventi...
www.biorxiv.org
November 14, 2026 at 6:32 AM
Can blood‑based T‑cell markers predict PD‑1 therapy response in melanoma? This study suggests yes, highlighting CD8⁺ proliferation in responders and CTLA‑4⁺ Tregs in non‑responders.

Read here📄 https://bit.ly/4pw1rVL
November 11, 2026 at 12:00 PM
🔥Highly Cited Review
#Immunotherapy in #ProstateCancer: From a “Cold” Tumor to a “Hot” Prospect
🧑‍⚕️by Whi-An Kwon and Jae Young Joung
📊50 citations
Unlock🔓 www.mdpi.com/2072-6694/17...
#AndrogenReceptor #OpenAccess #HighlyCited
November 12, 2026 at 7:58 AM
In MASLD, CD4−CD8− regulatory T cells had reduced mevalonate signaling. GGPP-dependent RAC1 modification supported their function in mouse experiments. These cells differ from conventional FOXP3+ Tregs; clinical translation remains open. 🧬 doi.org/10.1126/scia... #Tregs #MASLD
Mevalonate pathway regulates double-negative regulatory T cell stability in metabolic dysfunction–associated steatotic liver disease
Lipid metabolism dysfunction and immune imbalance are critical pathogenic drivers of metabolic dysfunction–associated steatotic liver disease (MASLD). Double-negative regulatory T cells (DNTreg) are…
doi.org
November 10, 2026 at 8:34 PM
Qa-1-restricted CD8+ Tregs protected mouse kidneys during Hantaan infection but delayed viral clearance in @pnas.org. Patient CD8+ Treg phenotypes correlated with severity. The trade-off: limiting tissue damage can weaken pathogen control. 🧬 doi.org/10.1073/pnas... #Tregs #Immunology
CD8+ regulatory T cells limit immunopathology but impair viral clearance in Hantaan virus infection | PNAS
In hemorrhagic fever with renal syndrome (HFRS) caused by Hantaan virus (HTNV), virus-specific CD8+ T cells mediate both viral clearance and immuno...
doi.org
November 9, 2026 at 5:14 PM
In this article, incomplete RFA triggers PIDD1, recruiting Tregs and causing HCC recurrence. Our study shows that targeting PIDD1 boosts anti-PD-1 therapy, blocking immune evasion and preventing tumor regrowth.
🔗 https://ow.ly/bI5h51018kE
November 9, 2026 at 3:15 PM
Not all Tregs are created equal! Shahram Kordasti from London in his amazing presentation suggest their role in AA and in MDS. Stay tune!!
#ESHCONFERENCES #ESHBMFS2026 #TREGS
November 7, 2026 at 3:54 PM
Open Access: Single-Cell Profiling Links T-Cell Accumulation and TH2/TH17 Dynamics to Eosinophilic Esophagitis (EoE) Activity in Children. First author: Hannes Hoelz; corresponding author: Tobias Schwerd

Read the article here: doi.org/10.1111/all.70517
November 10, 2026 at 8:37 AM
Can inflammatory signals support intestinal repair?

#Tregs coordinate IFNγ and IL-10 signaling to promote intestinal stem cell maintenance, epithelial regeneration and organoid growth after therapy-related injury. @tum.de @univparissaclay.bsky.social

#STTT #OpenAccess: doi.org/10.1038/s413...
November 7, 2026 at 2:00 AM
Luisa Barleben, Antony Schneegans, and scientists in Dr. Marina Kolesnichenko's lab at @mdc-berlin.bsky.social found that intestinal epithelial NF-κB signaling recruits Tregs to promote #inflammation resolution and tissue repair. 🩹

🔬 https://go.nature.com/4BCXg1y
Tune in: https://bit.ly/4f7D1iN
November 6, 2026 at 5:38 PM
RRID:AB_2737588 from @proteintech.bsky.social was used by authors in their Cell Reports Medicine paper. RRIDs improve reproducibility in scientific research. #RRID #OpenScience #reproducibility
Engineered receptor-biased IL-2–drug immunoconjugates selectively expand Tregs and suppress effector cells for autoimmune therapy
Read the full paper: Engineered receptor-biased IL-2–drug immunoconjugates selectively expand Tregs and suppress effector cells for autoimmune therapy
doi.org
November 7, 2026 at 8:00 AM